Literature DB >> 14675265

Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.

S P Thyagarajan1, Pallab Ray, Bimal Kumar Das, Archana Ayyagari, Aleem Ahmed Khan, S Dharmalingam, Usha Anand Rao, P Rajasambandam, B Ramathilagam, Deepak Bhasin, M P Sharma, S R Naik, C M Habibullah.   

Abstract

AIM: To assess the pattern of antimicrobial resistance of Helicobacter pylori isolates from peptic ulcer disease patients of Chandigarh, Delhi, Lucknow, Hyderabad and Chennai in India, and to recommend an updated anti-H. pylori treatment regimen to be used in these areas.
METHODS: Two hundred and fifty-nine H. pylori isolates from patients with peptic ulcer disease reporting for clinical management to the Post Graduate Institute of Medical Education and Research, Chandigarh; All India Institute of Medical Sciences, New Delhi; Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow; Deccan College of Medical Sciences and Allied Hospitals, Hyderabad; and hospitals in Chennai in collaboration with the Dr ALM Post Graduate Institute of Basic Medical Sciences were analyzed for their levels of antibiotic susceptibility to metronidazole, clarithromycin, amoxycillin, ciprofloxacin and tetracycline. The Epsilometer test (E-test), a quantitative disc diffusion antibiotic susceptibility testing method, was adopted in all the centers. The pattern of single and multiple resistance at the respective centers and at the national level were analyzed.
RESULTS: Overall H. pylori resistance rate was 77.9% to metronidazole, 44.7% to clarithromycin and 32.8% to amoxycillin. Multiple resistance was seen in 112/259 isolates (43.2%) and these were two/three and four drug resistance pattern to metronidazole, clarithromycin, amoxycillin observed (13.2, 32 and 2.56%, respectively). Metronidazole resistance was high in Lucknow, Chennai and Hyderabad (68, 88.2 and 100%, respectively) and moderate in Delhi (37.5%) and Chandigarh (38.2%). Ciprofloxacin and tetracycline resistance was the least, ranging from 1.0 to 4%.
CONCLUSION: In the Indian population, the prevalence of resistance of H. pylori is very high to metronidazole, moderate to clarithromycin and amoxycillin and low to ciprofloxacin and tetracycline. The rate of resistance was higher in southern India than in northern India. The E-test emerges as a reliable quantitative antibiotic susceptibility test. A change in antibiotic policy to provide scope for rotation of antibiotics in the treatment of H. pylori in India is a public health emergency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675265     DOI: 10.1046/j.1440-1746.2003.03174.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  29 in total

1.  Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh.

Authors:  Shamsun Nahar; Asish K Mukhopadhyay; Rasel Khan; Mian Mashhud Ahmad; Simanti Datta; Santanu Chattopadhyay; Swapan Chandra Dhar; Shafiqul Alam Sarker; Lars Engstrand; Douglas E Berg; G Balakrish Nair; Motiur Rahman
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.

Authors:  K K Mishra; S Srivastava; A Garg; A Ayyagari
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

3.  Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.

Authors:  Archana Chatterjee; Debasis Bagchi; Taharat Yasmin; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

5.  Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori.

Authors:  Adnan Khan; Amber Farooqui; Hamid Manzoor; Syed Shakeel Akhtar; Muhammad Saeed Quraishy; Shahana Urooj Kazmi
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

6.  Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.

Authors:  Mohamed H Emara; Salem Y Mohamed; Hesham R Abdel-Aziz
Journal:  Therap Adv Gastroenterol       Date:  2014-01       Impact factor: 4.409

7.  Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.

Authors:  Mukesh Nasa; Ajay Choksey; Aniruddha Phadke; Prabha Sawant
Journal:  Indian J Gastroenterol       Date:  2013-10-26

8.  Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes.

Authors:  Jeng Yih Wu; Jae J Kim; Rita Reddy; W M Wang; David Y Graham; Dong H Kwon
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

9.  Antimicrobial activity of Sapindus mukorossi and Rheum emodi extracts against H pylori: In vitro and in vivo studies.

Authors:  Mohammed Ibrahim; Aleem-A Khan; Santosh-K Tiwari; Mohammed-Aejaz Habeeb; M-N Khaja; C-M Habibullah
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

10.  The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam.

Authors:  Tran T Binh; Seiji Shiota; Lam T Nguyen; Dung D Q Ho; Hai H Hoang; Long Ta; Dung T Trinh; Toshio Fujioka; Yoshio Yamaoka
Journal:  J Clin Gastroenterol       Date:  2013-03       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.